Tag: Pharmaceutical

Alpha Cognition
Global

Alpha Cognition Announces Appointment of VP Finance and Accounting

October 21, 2024 – VANCOUVER, British Columbia – Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF)(“Alpha Cognition” or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, announces that Henry Du has joined Alpha Cognition as the VP of Finance and Accounting and interim Chief Financial Officer (CFO). “I am excited to join Alpha Cognition at such a critical juncture” Post … Continue reading Alpha Cognition Announces Appointment of VP Finance and Accounting

Impact Newswire
sanofi
Europe

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare

October 21, 2024 – Press Release Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Paris, October 21, 2024. Sanofi and CD&R announce today a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella. This new step in … Continue reading Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare

Impact Newswire
Luxa Biotechnology
United States

Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer

FORT LEE, N.J. – Luxa Biotechnology LLC (Luxa), a clinical -stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related macular degeneration (AMD), today announced the appointment of Keith Dionne, Ph.D. as Chief Executive Officer. “I am honored to join Luxa at such an exciting time” Post this An early pioneer in the cell therapy field and a … Continue reading Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer

Impact Newswire
Resilience
United States

Resilience Appoints Dr. Susan Billings, Chief Commercial Officer

SAN DIEGO – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced that Dr. Susan Billings will join the company as Chief Commercial Officer. In this pivotal role, Susan will lead Resilience’s commercial organization, focusing on brand building, revenue growth and market expansion to deliver exceptional customer-centric solutions across Resilience’s diverse biomanufacturing portfolio. “We are thrilled to welcome Susan … Continue reading Resilience Appoints Dr. Susan Billings, Chief Commercial Officer

Impact Newswire
John Murphy
United States

John Murphy Named President and CEO of AAM

Brings years of industry, policy, and association leadership experience WASHINGTON, DC (September 25, 2024) – The Association for Accessible Medicines Board of Directors today announced the appointment of John A. Murphy, III to be the association’s President and Chief Executive Officer. Mr. Murphy will join AAM in October. Mr. Murphy most recently served as the Chief Policy Officer at the Biotechnology Innovation Organization, where he … Continue reading John Murphy Named President and CEO of AAM

Impact Newswire